Compare RYAAY & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAAY | ALC |
|---|---|---|
| Founded | 1985 | 1945 |
| Country | Ireland | Switzerland |
| Employees | 27392 | N/A |
| Industry | Air Freight/Delivery Services | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7B | 32.4B |
| IPO Year | N/A | 2002 |
| Metric | RYAAY | ALC |
|---|---|---|
| Price | $65.21 | $69.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $78.00 | ★ $89.38 |
| AVG Volume (30 Days) | 893.6K | ★ 1.8M |
| Earning Date | 05-18-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.54% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.99 | $7.99 |
| Revenue Next Year | $6.32 | $6.38 |
| P/E Ratio | ★ $12.60 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.14 | $61.84 |
| 52 Week High | $74.24 | $92.55 |
| Indicator | RYAAY | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 58.86 |
| Support Level | $64.31 | $63.91 |
| Resistance Level | $65.44 | $82.09 |
| Average True Range (ATR) | 1.33 | 1.29 |
| MACD | 0.29 | 0.41 |
| Stochastic Oscillator | 85.26 | 98.63 |
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.